CHM chimeric therapeutics limited

Ann: New data for Phase 1A CLTX CAR T brain cancer clinical trial, page-75

  1. 912 Posts.
    lightbulb Created with Sketch. 577
    https://www.miragenews.com/car-t-cell-therapy-shows-promise-in-aggressive-1189756/
    https://www.nature.com/articles/s41591-024-02875-1?utm_source=miragenews&utm_medium=miragenews&utm_campaign=news

    Results from another phase 1 study from the the city of hope and our very own Christine Brown.

    Looks like their response rate and overall survival rate was very similar to our early phase 1a data.

    I dare say when we find the dose sweet spot and start dosing patients in the 2nd line of treatment, as opposed to the later lines, we'll improve upon both response and survival.

    Important to remember also "Chlorotoxin in the hands of city of hope has bound to the glioblastomas of more patients and more cells within those patients than any other agent they've tried."
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $432 98K

Buyers (Bids)

No. Vol. Price($)
26 22188206 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 25892021 31
View Market Depth
Last trade - 13.15pm 16/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.